178 related articles for article (PubMed ID: 37002577)
21. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
McGary EC; Weber K; Mills L; Doucet M; Lewis V; Lev DC; Fidler IJ; Bar-Eli M
Clin Cancer Res; 2002 Nov; 8(11):3584-91. PubMed ID: 12429650
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic targeting of platelet-derived growth factor receptors in solid tumors.
Ehnman M; Östman A
Expert Opin Investig Drugs; 2014 Feb; 23(2):211-26. PubMed ID: 24206431
[TBL] [Abstract][Full Text] [Related]
23. Platelet-derived growth factor (PDGF)-induced Ca2+ signaling in the CG4 oligodendroglial cell line and in transformed oligodendrocytes expressing the beta-PDGF receptor.
Fatatis A; Miller RJ
J Biol Chem; 1997 Feb; 272(7):4351-8. PubMed ID: 9020156
[TBL] [Abstract][Full Text] [Related]
24. The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.
Roskoski R
Pharmacol Res; 2018 Mar; 129():65-83. PubMed ID: 29408302
[TBL] [Abstract][Full Text] [Related]
25. Pathogenetic significance and possibility as a therapeutic target of platelet derived growth factor.
Ishii Y; Hamashima T; Yamamoto S; Sasahara M
Pathol Int; 2017 May; 67(5):235-246. PubMed ID: 28393435
[TBL] [Abstract][Full Text] [Related]
26. PDGFs and PDGFRs in canine osteosarcoma: new targets for innovative therapeutic strategies in comparative oncology.
Maniscalco L; Iussich S; Morello E; Martano M; Biolatti B; Riondato F; Della Salda L; Romanucci M; Malatesta D; Bongiovanni L; Tirrito F; Gattino F; Buracco P; De Maria R
Vet J; 2013 Jan; 195(1):41-7. PubMed ID: 22704137
[TBL] [Abstract][Full Text] [Related]
27. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
[TBL] [Abstract][Full Text] [Related]
28. PDGF/PDGFR axis in the neural systems.
Sil S; Periyasamy P; Thangaraj A; Chivero ET; Buch S
Mol Aspects Med; 2018 Aug; 62():63-74. PubMed ID: 29409855
[TBL] [Abstract][Full Text] [Related]
29. The roles of platelet-derived growth factors and their receptors in brain radiation necrosis.
Miyata T; Toho T; Nonoguchi N; Furuse M; Kuwabara H; Yoritsune E; Kawabata S; Kuroiwa T; Miyatake S
Radiat Oncol; 2014 Feb; 9():51. PubMed ID: 24512807
[TBL] [Abstract][Full Text] [Related]
30. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
31. Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer.
Ebert M; Yokoyama M; Friess H; Kobrin MS; Büchler MW; Korc M
Int J Cancer; 1995 Sep; 62(5):529-35. PubMed ID: 7665222
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
[TBL] [Abstract][Full Text] [Related]
33. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells.
Tian WN; Pignatare JN; Stanton RC
J Biol Chem; 1994 May; 269(20):14798-805. PubMed ID: 8182086
[TBL] [Abstract][Full Text] [Related]
34. Platelet-derived growth factors and receptors in Canine Lymphoma.
Aricò A; Guadagnin E; Ferraresso S; Gelain ME; Iussich S; Rütgen BC; Mazzariol S; Marconato L; Aresu L
J Comp Pathol; 2014 Nov; 151(4):322-8. PubMed ID: 25172054
[TBL] [Abstract][Full Text] [Related]
35. Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta.
Rui L; Carter-Su C
J Biol Chem; 1998 Aug; 273(33):21239-45. PubMed ID: 9694882
[TBL] [Abstract][Full Text] [Related]
36. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor signaling in human malignancies.
Liu KW; Hu B; Cheng SY
Chin J Cancer; 2011 Sep; 30(9):581-4. PubMed ID: 21880178
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of platelet-derived growth factor actions in the embryonic testis influences normal cord development and morphology.
Uzumcu M; Dirks KA; Skinner MK
Biol Reprod; 2002 Mar; 66(3):745-53. PubMed ID: 11870082
[TBL] [Abstract][Full Text] [Related]
39. Platelet-derived growth factor signaling and human cancer.
Yu J; Ustach C; Kim HR
J Biochem Mol Biol; 2003 Jan; 36(1):49-59. PubMed ID: 12542975
[TBL] [Abstract][Full Text] [Related]
40. PDGF-D, a new protease-activated growth factor.
LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
